Retour
Fourchette du Jour
87,99 €
90,94 €
Fourchette 52 Semaines
79,52 €
124,00 €
Volume
1 191 903
Moyenne 50J / 200J
105,31 €
/
104,33 €
Clôture Précédente
89,27 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -20,4 | 0,4 |
| P/B | 1,2 | 2,9 |
| ROE % | -5,7 | 3,7 |
| Net Margin % | -39,6 | 3,8 |
| Rev Growth 5Y % | -38,3 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue declined -38,26% annually over 5 years
Debt/Equity of 0,01 — conservative balance sheet
Generating 269,81M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38,46%
Capital efficient — spends only 6,10% of revenue on capex
Croissance
Revenue Growth (5Y)
-38,26%
Revenue (1Y)0,20%
Earnings (1Y)N/A
FCF Growth (3Y)-75,95%
Qualité
Return on Equity
-5,65%
ROIC-2,40%
Net Margin-39,59%
Op. Margin-22,63%
Sécurité
Debt / Equity
0,01
Current Ratio7,54
Interest Coverage-45,74
Valorisation
P/E Ratio
-20,36
P/B Ratio1,16
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,20% | Revenue Growth (3Y) | -15,04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -38,26% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,76B | Net Income (TTM) | -1,09B |
| ROE | -5,65% | ROA | -4,96% |
| Gross Margin | 77,64% | Operating Margin | -22,63% |
| Net Margin | -39,59% | Free Cash Flow (TTM) | 269,81M |
| ROIC | -2,40% | FCF Growth (3Y) | -75,95% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 7,54 |
| Interest Coverage | -45,74 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -20,36 | P/B Ratio | 1,16 |
| P/S Ratio | 8,06 | PEG Ratio | -0,29 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 22,22B | Enterprise Value | 14,81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,76B | 2,75B | 3,82B | 17,31B | 18,98B |
| Net Income | -1,09B | -665,30M | 930,30M | 9,43B | 10,29B |
| EPS (Diluted) | -4,51 | -2,77 | 3,83 | 37,09 | 41,21 |
| Gross Profit | 2,14B | 2,21B | 3,22B | 14,32B | 16,07B |
| Operating Income | -623,87M | -1,31B | 690,40M | 12,64B | 15,28B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 21,98B | 22,53B | 23,01B | 23,28B | 15,83B |
| Total Liabilities | 2,76B | 3,12B | 2,76B | 3,22B | 3,94B |
| Shareholders' Equity | 19,22B | 19,41B | 20,25B | 20,06B | 11,89B |
| Total Debt | 267,29M | 254,20M | 219,10M | 212,20M | 301,50M |
| Cash & Equivalents | 7,67B | 9,76B | 11,66B | 13,88B | 1,69B |
| Current Assets | 16,14B | 18,80B | 19,53B | 21,92B | 15,07B |
| Current Liabilities | 2,14B | 2,52B | 2,07B | 2,95B | 3,48B |